Product Information
RIVAROXABAN 1 MG/ML SUSPENSION is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.7938 per ML under NDC 70748035501. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
155 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748035501
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVAROXABANApproval Type
Generic (ANDA)
FDA Application
ANDA218195On Market Since
9/29/2025
Pharmacological Classes
Price Statistics
The NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7938 per ML |
|---|---|
| All-time high | $2.0669 (Feb 11, 2026) |
| All-time low | $1.7938 (Jun 17, 2026) |
| 52-week high | $2.0669 |
| 52-week low | $1.7938 |
| Median price | $1.9574 |
| Average price | $1.9634 |
| Largest weekly change | -4.0% (Apr 22, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the rivaroxaban granule market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RIVAROXABAN 1 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 1 MG/ML SUSPENSION, manufactured by Lupin Pharmaceuticals Inc., is $1.7938 per ML (NDC 70748035501), effective Jun 24, 2026.
How has the price of RIVAROXABAN 1 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has declined 13.2%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for RIVAROXABAN 1 MG/ML SUSPENSION?
Since Dec 17, 2025, the NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has ranged from a low of $1.7938 (Jun 17, 2026) to a high of $2.0669 (Feb 11, 2026), with a median of $1.9574 per ML.
Are there cheaper alternatives to RIVAROXABAN 1 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RIVAROXABAN 1 MG/ML SUSPENSION, so no direct lower-cost alternative is listed.
Who manufactures RIVAROXABAN 1 MG/ML SUSPENSION?
RIVAROXABAN 1 MG/ML SUSPENSION (NDC 70748035501) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification